Informationsseite des RKI rund um Impfen und COVID-19
Leitfaden für Ärzt:innen im Patient:innen- und Bürger:innengespräch
Informationen rund um die Corona-Schutzimpfung
Diese Informationen sind zur Weitergabe an Patient:innen und Bürger:innen.
Unsere Infoboxen zeigen das Ansteckungs-, Erkrankungs- und Sterberisiko für Menschen verschiedenen Alters, wenn sie in Kontakt mit dem Influenza- oder Corona-Virus kommen (z.B. durch engen Kontakt mit einem infizierten Haushaltsmitglied) und die Risiken eines engen Kontaktes für Menschen verschied...enen Alters, wenn man selbst mit dem Influenza- oder Corona-Virus infiziert ist.
Zu jeder Infobox finden Sie im Begleittext Hintergrundinformationen zur Erstellung und zu den dahinter liegenden Daten.
more
On 20 March 2020, Pope Francis asked the Dicastery for Promoting Integral Human Development (DPIHD) to create a Commission, in collaboration with other Dicasteries of the Roman Curia and other organizations, to express the Church’s solicitude and care for the whole human family facing the COVID-19... pandemic, including analysis, reflection on the new socio-economic-cultural future, and the proposal of relevant approaches.
Accordingly, DPIHD has established a Vatican COVID-19 Commission to take up the Pope’s concern through the activities of five Working Groups, which are: acting now for the future; looking to the future with creativity; communicating hope; seeking common dialogue and reflections; supporting to care.
more
Die Bundesländer sind für die Organisation der Impfung gegen Corona zuständig. Sie betreiben die Impfzentren, vergeben Termine und planen den Einsatz der mobilen Teams in Pflegeheimen. Hier finden Sie die Infoseite Ihres Bundeslandes zur Corona-Schutzimpfung.
YouTube influencer Healthcare Triage talked with WHO's Dr Kate O'Brien about how the COVID-19 vaccine works, how it gets distributed, and how we distribute it equitably.
1:27 Safety questions and concerns about quick development of the vaccine.
7:18 Have we entered a new age where all vaccines wi...ll be developed this easily and quickly?
8:41 Questions about vaccine distribution – how’s it gonna work?
10:36 How do we make sure we distribute the vaccine equitably?
11:59 How do we make sure all countries get the same seat at the vaccine table?
13:29 What are reasonable expectations about the vaccine and life returning to “normal”?
15:14 Misinformation about the vaccine
17:00 Specific myths about the vaccine
18:18 The bigger picture – what have we learned from this pandemic that we should apply in the future?
more
English Analysis on World and 19 other countries about Agriculture, Food and Nutrition and Drought; published on 13 Jan 2021 by FAO
English Analysis on World about Disaster Management and Protection and Human Rights; published on 12 Jan 2021 by IFRC
Comirnaty® 10 μg und 30 μg von BioNTech / Pfizer und Spikevax® von Moderna
Seit über einem Jahr hat die Corona-Pandemie große Veränderungen für alle Menschen in nahezu jedem Lebensbereich herbeigeführt. Geflüchtete in (Erst-) Aufnahmeeinrichtungen und Gemeinschaftsunterkünften sind in besonderem Maße von der Pandemie betroffen, da die vorgefundenen Wohnbedingungen ...einen kaum ausreichenden Schutz zulassen. Obwohl gerade die Bewohner*innen von Sammelunterkünften dem Virus stark ausgesetzt sind, hat diese Gruppe nicht ausreichend Beachtung und Schutz gefunden. Ergriffene Maßnahmen wie etwa Kollektiv- oder auch Kettenquarantänen haben die Lebensbedingungen der Bewohner*innen noch weiter erschwert, mit gravierenden Auswirkungen auf das Asylverfahren, Gesundheit, Beruf, Ausbildung und Schule und so letztendlich auch auf ihre soziale Teilhabe.
more
orientations provisoires, première publication le 25 janvier 2021, mise à jour le 15 juin 2021, mise à jour le 19 novembre 2021
Climate change and health vulnerability and adaptation assessment
In 2013 the World Health Organization (WHO) published the report Protecting health from climate change:
vulnerability and adaptation assessment. The aim was to provide basic and flexible guidance on conducting national or subnati...onal assessments of current and future vulnerability (the susceptibility of a population or region to harm) to the health risks of climate change, and of policies and programmes that could increase resilience, taking into account the multiple determinants of climate-sensitive health outcomes.
That guidance has been a very useful tool, applied to more than 50 countries and settings, and has helped countries to prepare their health contributions to United Nations Framework Convention on Climate Change national adaptation plans.
Since the launch of the guidance, WHO, technical partners such as Health Canada, and countries have learned much in terms of its applicability in different countries, at national and local levels.
At the same time, knowledge on climate change and health has increased.
WHO, the Pan American Health Organization and Health Canada have produced this updated version, which aims to better support countries in their assessments by proposing a simpler tool that incorporates all lessons learned.
more
Herd immunity by mass vaccination offers the potential to substantially limit the continuing spread of COVID-19, but high levels of vaccine hesitancy threaten this goal. In a cross-country analysis of vaccine hesitant respondents across Latin America in January 2021, we experimentally tested how fiv...e features of mass vaccination campaigns—the vaccine’s producer, efficacy, endorser, distributor, and current population uptake rate—shifted willingness to take a COVID-19 vaccine. We find that citizens preferred Western-produced vaccines, but were highly influenced by factual information about vaccine efficacy. Vaccine hesitant individuals were more responsive to vaccine messengers with medical expertise than political, religious, or media elite endorsements. Citizen trust in foreign governments, domestic leaders, and state institutions moderated the effects of the campaign features on vaccine acceptance. These findings can help inform the design of unfolding mass inoculation campaigns.
more
COVID-19 vaccine hesitancy is currently one of the main obstacles to worldwide herd immunity and socioeconomic recovery. Because vaccine coverage can vary between and within countries, it is important
to identify sources of variation so that policies can be tailored to different population groups. ...In this paper, we analyze the results from a survey designed and implemented in order to identify early adopters and
laggers in six big cities of Latin America. We find that trust in government and science, accurate knowledge about the value of vaccination and vaccine effects, perceived risk of getting sick, and being a student
increase the odds to get vaccinated. We also identify potential laggers as women and populations between 20 and 35 years old who are not students. We discuss specific strategies to promote vaccination among
these populations groups as well as more general strategies designed to gain trust. These findings are specific to the context of Latin America insofar as the underlying factors associated with the choice to be
vaccinated vary significantly by location and in relation to individual-level factors.
more
Ce glossaire actualisé sur le paludisme vise à améliorer la communication et la compréhension mutuelle au sein de la communauté scientifique, ainsi qu'avec les organismes de financement, les responsables de la santé publique chargés des programmes de lutte contre le paludisme et les décideur...s des pays où le paludisme est endémique.
more